Matthew Grimes, MD
Urology · Madison, WINPI 1386087740
Payments from drug & device makers
What this record shows
Every reported general payment came from a single manufacturer, Boston Scientific. Reporting peaked in 2019 at $477 and has fallen 90.8% since, to $44 in 2025. That places this record below the midpoint for urology clinicians in WI, where the typical reported total is $673.
Across 9 payments — averaging $74.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$668
Across 2 payments — averaging $138,484 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$277K
What the payments were for
- Travel & lodging$39759%
- Food & beverage$27241%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $668 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS$350
- GENERAL ERECTILE DYSFUNCTION$115
How this compares
$668 in reported general payments places this provider in the 45th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 29 | $14,992 |
| Oxybutynin Chloride ErOxybutynin Chloride | 22 | $927 |
| Tamsulosin Hcl | 32 | $471 |
| Solifenacin Succinate | 16 | $454 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 37 | $64 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other urology in Madison
- Dan GralnekMadison$142K
- Christopher ManakasMadison$87K
- Javier SantiagoMadison$57K
- Margaret KnoedlerMadison$31K
- Edwin AbelMadison$22K
- Stephen NakadaMadison$11K
- Kyle RichardsMadison$9K
- Reginald BruskewitzMadison$8K
- Sara BestMadison$7K
- Daniel RoadmanMadison$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.